EPA Reorganizes Research OfficeORD Dissolved, IRIS Under Fire

In the middle of debates over climate change, “forever chemicals,” and air pollution, the U.S. Environmental Protection Agency (EPA) has done something dramatic: it has dissolved its long-standing Office of Research and Development (ORD) and is shuffling scientists into a new structure, all while its flagship chemical risk program, the Integrated Risk Information System (IRIS), is taking heat from just about everyone. Supporters call it a badly needed modernization. Critics see it as taking the “science” out of a science-based agency. Either way, this is not a routine org chart tweakit’s a full-on shakeup of how environmental science will inform U.S. regulations for years to come.

What Exactly Did EPA Just Do to Its Research Office?

From ORD to OASES

For decades, ORD functioned as the EPA’s in-house research engine, employing roughly 1,000–1,500 scientists and technical staff spread across specialized labs and centers. In 2025, EPA leadership announced plans to dissolve ORD, cut thousands of positions agency-wide, and shift remaining scientists into a new entity: the Office of Applied Science and Environmental Solutions (OASES), housed directly within the Administrator’s office rather than operating as a more independent research arm.

According to agency press materials and budget justifications, this reorganization is framed as a way to streamline EPA, save roughly three-quarters of a billion dollars, and “align research with core regulatory programs.” The workforce reduction is steep: news reports describe staff cuts of about 23%, with more than 3,700 positions affected and only a fraction of former ORD scientists guaranteed new roles. Many research staff have faced early-retirement offers, reassignment, or outright layoffs.

Why Now?

The timing is not accidental. The changes align with a broader push by the Trump administration to shrink the federal workforce, reduce regulatory burdens, and reorient agencies toward “economic growth” and “efficiency.” EPA leadership argues that embedding OASES next to the Administrator will keep science “at the table” for big decisions and make research more responsive to immediate regulatory needs.

Critics, including unions, environmental groups, and many academic scientists, see it very differently. They warn that moving research under direct political oversight makes it easier to pressure scientists, slow or shape findings that might support stricter environmental rules, and prioritize short-term political goals over decades-long health and climate risks.

Why the Office of Research and Development Mattered So Much

ORD: EPA’s Scientific Backbone

ORD was never a household name, but its fingerprints are all over modern environmental protections. ORD scientists helped characterize the health effects of air pollution, studied how contaminants move through soil and groundwater, and provided critical evidence on toxic substances like lead, PFAS “forever chemicals,” and ozone-forming pollutants. Their work showed up in the background documents that justify National Ambient Air Quality Standards, drinking water regulations, and cleanup decisions at contaminated sites.

Unlike program offices that are tied directly to day-to-day permitting or enforcement, ORD focused on longer-term research: big multi-year studies, method development, and foundational risk assessments that give regulators the scientific footing to act. That independenceboth scientific and organizationalis what many observers fear is being lost as ORD disappears and its staff are redistributed.

From Long-Term Research to Short-Term Politics?

ORD’s dissolution raises a practical question: who, exactly, will do the deep, slow work of understanding emerging threats? Historically, ORD’s long-horizon work has helped reveal hazards before they were obvious to the broader public, from harmful air toxics to chemical contaminants in drinking water. Without a robust, relatively insulated research arm, there is concern that EPA will become more reactivewaiting for crises rather than building the science to prevent them.

Supporters of the reorganization insist that OASES can still deliver high-quality science; it will simply be more “mission focused.” But critics worry that “mission focused” is code for “aligned with current political messaging,” and that scientists may feel pressure to avoid findings that complicate deregulatory agendas or industry priorities.

IRIS Under Fire: The Chemical Risk Program Everyone Loves to Hate

What Is IRIS, Anyway?

The Integrated Risk Information System (IRIS) is EPA’s long-standing program for evaluating the toxicity of chemicals. IRIS produces detailed assessments of substances like benzene, formaldehyde, and per- and polyfluoroalkyl substances (PFAS), estimating how much exposure is likely to increase risks of cancer, developmental harms, or organ damage. Those numbers don’t automatically trigger regulations, but they heavily influence drinking water standards, cleanup decisions, workplace exposure limits, and international guidelines.

IRIS assessments are widely used not just by EPA, but by states, federal agencies, and regulators around the world. That makes IRIS a very big deal, and also a very big target. When IRIS suggests a chemical is more dangerous than previously thought, it can set off alarm bells in industries that rely on that substanceand in communities that have been living with it for years.

Why Critics Say IRIS Is Flawed

The IRIS program has been under scrutiny for years from multiple directions:

• Slow and backlogged. The Government Accountability Office (GAO) flagged IRIS more than a decade ago for being too slow and at risk of becoming obsolete because assessments took so long to complete. Backlogs of dozens of chemicals were common.
• Methodological disputes. Industry groups and some trade associations argue that IRIS has used overly conservative assumptions, questionable dose-response models, and insufficiently transparent methods. They say that exaggerated risk estimates drive overly strict standards and unnecessary costs.
• Process concerns. Critics outside government have complained about inconsistent timelines, frequent changes to the assessment process, and limited opportunities for meaningful early input from other federal agencies and stakeholders.

These concerns have led to calls for “IRIS reform” from both business groups and some policymakers. Reorganization of EPA’s research functions has been pitched, in part, as a way to fix an allegedly broken system and align chemical risk work more closely with the agency’s newer legal frameworks under the Toxic Substances Control Act (TSCA).

The Case for Protecting IRIS

On the other side, public health advocates, many scientists, and environmental groups argue that IRIS’s central problem is not that it is too conservative or too independent, but that it has been interfered with too often. They point out that:

• IRIS is one of the few programs designed to look across all exposure sourcesair, water, soil, consumer productsand provide a consistent view of hazard, rather than focusing on one narrow statute.
• Past reforms, including recommendations from the National Academies, have already substantially improved IRIS’s transparency, peer review processes, and use of modern risk-assessment methods.
• Without a strong, independent IRIS, regulation could fall back on short, case-by-case analyses that are more vulnerable to political or industry pressure.

From this perspective, the current reorganization is less about improving science and more about sidelining a program that sometimes delivers inconvenient truthslike finding that widely used substances may be carcinogenic or more harmful than previously thought.

Is This About Science, or About Power?

Consolidation Under the Administrator

One of the most controversial aspects of the reorganization is not just that ORD is gone, but where its remnants are going. OASES is being placed directly within the Office of the Administrator, an office that is inherently political. In theory, this proximity could make it easier for scientists to get their work in front of top decision-makers. In practice, it may also make it easier for those same decision-makers to lean on scientists when scientific conclusions clash with political goals.

Former EPA officials warn that this arrangement risks “micromanaging” sciencesubtle pressure to adjust assumptions here, delay a publication there, or quietly shelve research that would support stricter standards for pollution or climate-warming emissions. Even if overt censorship never happens, the fear of retaliation can be enough to chill scientific candor.

Budget Cuts and Brain Drain

You cannot reorganize your way out of a 23% workforce reduction without consequences. Eliminating ORD and cutting thousands of employees means losing years, sometimes decades, of specialized expertise. As layoff notices and early retirement offers have gone out, many remaining scientists have opted to leave for universities, nonprofits, or private consulting.

This “brain drain” doesn’t just affect internal morale; it affects the entire regulatory ecosystem. States often rely on EPA scientists for technical guidance. International partners depend on EPA research for global standards. Once that expertise disperses, rebuilding it is slow, expensive, and uncertainespecially if young scientists perceive EPA as a risky or unstable career choice.

What the Reorganization Means for Health, Industry, and Communities

Public Health Risks

From a public-health perspective, the biggest fear is that fewer independent scientists inside EPA plus a weakened IRIS program will translate into laxer standards, delayed protections, or both. Risk assessments are the foundation for rules that limit contaminants in drinking water, reduce air toxics in frontline communities, and manage the cleanup of hazardous waste sites. If those assessments slow down or are tilted toward minimizing risk, people living near industrial facilities, highways, or contaminated sites could face higher exposures for longer.

Communities that have fought for years for recognition of their environmental burdensfence-line neighborhoods, rural towns near industrial agriculture, tribal lands impacted by miningmay find it harder to secure protective decisions if the science they rely on is weakened or delayed.

Regulatory Certainty for Industry

Ironically, industry could also suffer if scientific capacity erodes. While some companies may welcome less stringent rules in the short term, most heavily regulated sectorschemicals, energy, manufacturingprefer predictable, science-based standards. Unclear or unstable risk assessments can lead to litigation, shifting requirements, and reputational risk as states or foreign regulators step in with stricter rules.

Robust, credible science can actually support innovation by clarifying which substances are too risky and which are safer alternatives. If IRIS and OASES are perceived as politicized or technically weak, other institutionsstates, other countries, or even private standard-settersmay fill the vacuum, creating a patchwork of requirements that is harder for companies to navigate.

Environmental Justice Concerns

Many of the communities most affected by pollution are already overburdened and under-resourced. They often rely heavily on EPA science to make their case. When a neighborhood group shows up to a public meeting and says, “Our air has higher levels of this chemical, and EPA’s own assessment says it raises cancer risk,” that’s a powerful argument.

If IRIS assessments shrink in scope, become slower, or are perceived as less trustworthy, those community advocates lose one of their strongest tools. The reorganization, then, isn’t just about internal lines on an org chartit’s about who gets to claim the backing of science in environmental fights.

Congress, Courts, and the Next Phase of the Fight

Capitol Hill and Oversight

Members of Congress from both parties have raised questions about the scale and speed of EPA’s restructuring. Appropriators have considered using funding bills to slow or block parts of the reorganization, while oversight committees have requested more detail on how scientific integrity will be protected. Congressional researchers have flagged the ORD and IRIS changes as key issues to watch as legislators weigh EPA’s budget and statutory obligations under cornerstone laws like the Clean Air Act and Safe Drinking Water Act.

The basic tension is simple: Can EPA still meet its legal duty to protect public health and the environment if its main research arm and core chemical risk program are significantly weakened, repackaged, or placed under tighter political control?

Court Challenges and Scientific Integrity Policies

Legal challenges are already circling, including cases brought by former employees and advocacy groups arguing that massive staff reductions and structural changes have chilled speech, undermined scientific integrity, or violated civil-service protections. Courts may ultimately decide how far an administration can go in reshaping a science-based agency in the name of efficiency or deregulation.

At the same time, EPA’s own scientific integrity policiesrules meant to protect scientists from political interferenceare under stress. They were not designed with the wholesale elimination of an entire research office in mind. Whether those policies can be enforced robustly in a reorganized EPA will be a crucial test of their real-world value.

What to Watch Next

The reorganization of EPA’s research enterprise is not a one-day story. Over the next few years, key indicators will show whether this is a painful but ultimately constructive modernizationor a turning point where science lost ground to politics:

• Staffing trends. Does EPA retain and recruit high-level scientists, or does the talent pool continue to drain away?
• IRIS output. Do new assessments continue to be published, with transparent methods and robust peer review, or does the pipeline slow to a trickle?
• Regulatory actions. Are new rules on emerging contaminants, climate-related health risks, and industrial pollution grounded in strong scienceor built on thinner, less transparent analyses?
• State and international responses. Do states and foreign regulators begin to rely less on EPA science and more on their own assessments or international bodies?

For now, the only thing that’s clear is that the stakes are high. ORD may be gone from the org chart, but the questions it was created to answerwhat is safe, what is harmful, and how much risk are we willing to tolerateare not going anywhere.

On the Ground: Experiences from Inside and Outside EPA

Reorganizations can sound sterile when you only talk in percentages and acronyms. To understand what “ORD dissolved, IRIS under fire” really means, it helps to zoom in on the people and places living through it.

A Toxicologist Packs Up Her Lab

Imagine a career EPA toxicologist who has spent 18 years working on PFAS and other persistent chemicals. Her lab has long been part of ORD, collaborating with universities and state agencies to develop better test methods and understand how these substances move through drinking-water systems. She has watched small towns discover contamination because ORD’s work made it possible to measure these chemicals in the first place.

When the reorganization memo drops, her division is told that some positions will move into OASES, others will shift into separate program offices, and still others will be eliminated entirely. The guidance is vague, and the timelines are short. She spends weeks unsure whether she will have a job, and if she does, whether it will still involve hands-on research or mostly reviewing industry submissions under tight deadlines.

In conversations with colleagues, she hears the same refrain: “We came to EPA because we wanted to do independent science for the public good. Will we still be allowed to do that?” Some decide they can’t wait to find out and accept offers at universities or consulting firms. She decides to stayfor nowbut boxes up long-running projects that no longer have a clear home. The science doesn’t stop overnight, but the pace slows, and the uncertainty seeps into every decision.

A Small Town Loses a Lifeline

Hundreds of miles away, a small town that relies on a shallow aquifer is struggling with a different kind of uncertainty. Residents have been worried about a nearby industrial facility for years, and local officials have been working with EPA scientists to interpret monitoring data and plan a long-term response. ORD staff previously provided technical assistance, helping local regulators understand which contaminants deserved priority and what kinds of treatment systems would actually work for their budget.

After the reorganization, calls to longtime ORD contacts start going to voicemail. The scientists they relied on are either gone, reassigned, or suddenly swamped with new responsibilities. Local officials find themselves bounced between offices, with no clear point of contact and no guarantee that specialized expertise is still available.

It’s not that EPA disappears; regional offices are still there, and new OASES staff eventually reach out. But the continuity is gone, and the town’s leaders sense that the agency is more cautious, more scripted, and less willing to speak frankly about what the latest toxicology suggests. For a community already skeptical about government promises, that perceived retreat from open science feels like another broken trust.

Industry Seeks Clarity in a Moving Landscape

Meanwhile, an environmental, health, and safety (EHS) manager at a mid-sized chemical manufacturer is watching IRIS closely. Her job depends on understanding where EPA science is headed so her company can plan investments, adjust product lines, and avoid surprises. In the past, while IRIS assessments could be frustratingly slow, they were at least a known process: long drafts, peer review, external science advisory input.

Under the new setup, she hears that IRIS is being “reformed,” its work refocused, and its staff partially reassigned. Some industry groups cheer; they’ve spent years arguing that IRIS was too conservative and inconsistent. But she is not entirely reassured. Delays or pauses in IRIS assessments make it harder to know whether the chemicals her company relies on will be deemed higher-risk in the future. If EPA’s internal science becomes less transparent or more obviously political, state regulators and foreign governments might respond by tightening their own standardsor blacklisting certain substances entirely.

For her, “IRIS under fire” is not simply a win. It’s a sign that the ground rules are shifting, and that her company may face a patchwork of conflicting requirements. She’d prefer tough, predictable rules over endlessly shifting ones.

Why These Experiences Matter

Taken together, these experiences underscore what’s at stake in the EPA’s research reorganization. The disappearance of ORD is not an abstract bureaucratic tweak. It changes the daily reality for scientists who chose public service over private-sector careers, for communities navigating complex pollution problems, and for companies trying to plan responsibly in a heavily regulated space.

Whether the new structure ultimately strengthens or weakens environmental protection will depend on choices made in the next few years: how many scientists EPA keeps, how openly IRIS operates, how strongly scientific integrity is enforced, and how willing leaders are to hearand act onuncomfortable evidence. Reorganizations can be reversed; lost trust and lost time are much harder to get back.